1d
Universal, ready-to-use immunotherapy detects and destroys endometrial cancer in preclinical tests
Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival ...
Despite the increased incidence of endometrial cancer in younger women, there is limited research regarding the safety of local, low-dose vaginal estrogen therapy (ET) for survivors. A new study ...
COMBINED therapy with GLP 1 receptor agonists and progestins is associated with a significantly lower risk of endometrial cancer in women with benign uterine disease or endometrial hyperplasia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results